We are company builders.

Canaan Partners Closes $600 Million Fund, Canaan IX

Global venture capital firm closes 9th fund to fuel investment in global healthcare and technology pioneers, bringing total capital under management to $3.5B

Canaan Partners, a multi-billion dollar, global venture capital firm, announced today the closing of a $600 million fund, Canaan IX. The new fund brings total capital under management to $3.5 billion and will enable the firm to continue backing visionary entrepreneurs who are building disruptive global companies...

  • PORTFOLIO NEWS
  • CANAAN EVENTS
  • CANAAN NEWS

Chimerix Awarded BARDA Contract for Advanced Development of Broad Spectrum Antiviral CMX001 as Medical Countermeasure Against Smallpox
Chimerix will receive committed funding of $24.8 million during the first year...

Zuberance Interview with Eileen Gittins on How Blurb Cut Customer Acquisition Costs in Half
Eileen discusses the tremendous impact that working with Zuberance has had on Blurb's marketing...

Durata Therapeutics Receives Positive Scientific Advice from European Medicines Agency (EMA)
Clear Regulatory Path forward in All Major Regions...